Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
Antidromic median sensory nerve action potential |
The recording electrodes were placed on the second finger and the stimulus will be applied on the median nerve (above the elbow joint). The stimulus will consist of a train of 10 pulses (100 µs width), applied at supramaximal stimulation, presented at 1 Hz (DS7A, Digitimer Ltd). Negative peak latency (NPL), positive peak latency (PPL), and peak-to-peak amplitude (PPA) will be registered with a specific software (Signal software, CED). |
Baseline at 0 minutes |
|
Primary |
Tactile Threshold |
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton |
Baseline at 0 minutes |
|
Primary |
Oscillation Frequency of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The frequency of the damped oscillations characterizes the muscle tone. The muscle will be assessed is opponens pollicis muscle |
Baseline at 0 minutes |
|
Primary |
Stiffness of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle. The muscle will be assessed is opponens pollicis muscle |
Baseline at 0 minutes |
|
Primary |
Decrement (elasticity) of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The logarithmic decrement of the damping oscillations characterizes muscle elasticity which is the ability of the muscle to restore its initial shape after contraction. The muscle will be assessed is opponens pollicis muscle |
Baseline at 0 minutes |
|
Primary |
Pressure Pain Threshold |
The PPT will be measured with an algometer and will be expressed in Newtons |
Baseline at 0 minutes |
|
Primary |
Muscle strength |
Muscle strength will be measured with a dynamometer and will be expressed in Kgs. |
Baseline at 0 minutes |
|
Primary |
Tactile Threshold |
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton |
During treatment at 15 minutes |
|
Primary |
Oscillation Frequency of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The frequency of the damped oscillations characterizes the muscle tone. The muscle will be assessed is opponens pollicis muscle |
During treatment at 15 minutes |
|
Primary |
Stiffness of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle. The muscle will be assessed is opponens pollicis muscle |
During treatment at 15 minutes |
|
Primary |
Decrement (elasticity) of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The logarithmic decrement of the damping oscillations characterizes muscle elasticity which is the ability of the muscle to restore its initial shape after contraction. The muscle will be assessed is opponens pollicis muscle |
During treatment at 15 minutes |
|
Primary |
Pressure Pain Threshold |
The PPT will be measured with an algometer and will be expressed in Newtons |
During treatment at 15 minutes |
|
Primary |
Antidromic median sensory nerve action potential |
The recording electrodes were placed on the second finger and the stimulus will be applied on the median nerve (above the elbow joint). The stimulus will consist of a train of 10 pulses (100 µs width), applied at supramaximal stimulation, presented at 1 Hz (DS7A, Digitimer Ltd). Negative peak latency (NPL), positive peak latency (PPL), and peak-to-peak amplitude (PPA) will be registered with a specific software (Signal software, CED). |
Immediately after treatment at 20 minutes |
|
Primary |
Tactile Threshold |
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton |
Immediately after treatment at 20 minutes |
|
Primary |
Oscillation Frequency of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The frequency of the damped oscillations characterizes the muscle tone. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 20 minutes |
|
Primary |
Stiffness of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 20 minutes |
|
Primary |
Decrement (elasticity) of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The logarithmic decrement of the damping oscillations characterizes muscle elasticity which is the ability of the muscle to restore its initial shape after contraction. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 20 minutes |
|
Primary |
Pressure Pain Threshold |
The PPT will be measured with an algometer and will be expressed in Newtons |
Immediately after treatment at 20 minutes |
|
Primary |
Muscle strength |
Muscle strength will be measured with a dynamometer and will be expressed in Kgs. |
Immediately after treatment at 20 minutes |
|
Primary |
Antidromic median sensory nerve action potential |
The recording electrodes were placed on the second finger and the stimulus will be applied on the median nerve (above the elbow joint). The stimulus will consist of a train of 10 pulses (100 µs width), applied at supramaximal stimulation, presented at 1 Hz (DS7A, Digitimer Ltd). Negative peak latency (NPL), positive peak latency (PPL), and peak-to-peak amplitude (PPA) will be registered with a specific software (Signal software, CED). |
Immediately after treatment at 30 minutes |
|
Primary |
Tactile Threshold |
The tactile threshold will be measured with Von Frey filaments and will be expressed in millinewton |
Immediately after treatment at 30 minutes |
|
Primary |
Oscillation Frequency of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The frequency of the damped oscillations characterizes the muscle tone. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 30 minutes |
|
Primary |
Stiffness of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 30 minutes |
|
Primary |
Decrement (elasticity) of tissue assessed by MyotonPro |
This outcome measure is obtained by a device named MyotonPro. The logarithmic decrement of the damping oscillations characterizes muscle elasticity which is the ability of the muscle to restore its initial shape after contraction. The muscle will be assessed is opponens pollicis muscle |
Immediately after treatment at 30 minutes |
|
Primary |
Pressure Pain Threshold |
The PPT will be measured with an algometer and will be expressed in Newtons |
Immediately after treatment at 30 minutes |
|
Primary |
Muscle strength |
Muscle strength will be measured with a dynamometer and will be expressed in Kgs. |
Immediately after treatment at 30 minutes |
|
Secondary |
Baseline nerve temperature |
Nerve temperature will be measured using a termodoppler (Celsius degrees) |
Baseline at 0 minutes, at 15 minutes, immediately after treatment at 20 minutes, and immediately after treatment at 30 minutes |
|
Secondary |
Baseline flux temperature |
Flux will be measured using a termodoppler |
Baseline at 0 minutes, at 15 minutes, immediately after treatment at 20 minutes, and immediately after treatment at 30 minutes |
|
Secondary |
Numerical Discomfort Rate Score |
the possible discomfort caused by the interventions will be assess by a numerical rate score. The NRS consists of a scale from 0 (no discomfort) to 10 (worst possible discomfort) |
After the intervention at 35 minutes |
|
Secondary |
Numerical Pain Rate Score |
The NRS consists of a scale from 0 (no pain) to 10 (worst possible pain) |
After the intervention at 35 minutes |
|
Secondary |
Number of participants with intervention-related adverse effects |
the possible adverse effects caused by the interventions will be assess by a questionnaire |
After the intervention at 35 minutes |
|
Secondary |
Blinding success |
Blinding of subjects and researchers will be assessed using the James Index |
After the intervention at 35 minutes |
|